Upon activation the human bradykinin B 2 receptor (B 2 R) acts as guanine nucleotide exchange factor for the G proteins G q/11 and G i . Thereafter, it gets phosphorylated by G protein-coupled receptor kinases (GRKs) and recruits !-arrestins, which block further G protein activation and promote B 2 R internalization via clathrin-coated pits. Like for most G protein-coupled receptors (GPCRs) of family A, an intracellular helix 8 following transmembrane domain 7 is also predicted for the B 2 R. We show here that disruption of helix 8 in the B 2 R by either Cterminal truncation or just by mutation of a central amino acid (K315) to a helix-breaking proline resulted in strong reduction of surface expression. Interestingly, this malfunction could be overcome by addition of the membrane-permeable B 2 R antagonist JSM10292, suggesting that helix 8 has a general role for conformational stabilization that can be accounted for by an appropriate antagonist. Intriguingly, an intact helix 8, but not the C-terminus with its phosphorylation sites, was indispensable for receptor sequestration and for interaction of the B 2 R with GRK2/3 and !-arrestin2 as shown by coimmunoprecipitation. Recruitment of !-arrestin1, however, required the presence of the C-terminus. Taken together, our results demonstrate that helix 8 of the B 2 R plays a crucial role not only in efficient trafficking to the plasma membrane or the activation of G proteins, but also for the interaction of the B 2 R with GRK2/3 and !-arrestins. Additional data obtained with chimera of B 2 R with other GPCRs of family A suggest that helix 8 might have similar functions in other GPCRs, too.
The human bradykinin B 2 receptor (B 2 R) belongs to the family A (rhodopsin / !-adrenergic-like) of G protein-coupled receptors (GPCRs). The B 2 R is ubiquitously expressed in many cells and tissues and its activation results in a variety of physiological effects that range from vasodilatation and increased vascular permeability to hyperalgesia and natriuresis (1) . Recent studies with B 2 R knockout mice also point to a protective role of the B 2 R in the process of aging and in diabetes (2) . After extracellular binding of its endogenous agonists, of the nona-peptide bradykinin (BK) or of kallidin (Lys-BK), the B 2 R undergoes conformational changes that turn it into a guanine nucleotide exchange factor for the G proteins G q/11 and G i thus leading to the activation of G protein-dependent signaling cascades. Among other events, this results in phosphatidyl inositol hydrolysis and activation of MAPK pathways. As reported for many GPCRs, desensitization of the B 2 R comes along with phosphorylation of serine/threonine residues in its C-terminus by G protein-coupled receptor kinases (GRKs) or second messenger kinases as well as recruitment of !-arrestins and ends with the sequestration of the receptor into intracellular compartments (1) . Upon short-term stimulation the receptor gets recycled to the plasma membrane, whereas long-term stimulation leads to the downregulation of the receptor (3) (4) (5) . Currently, only limited information is available on the molecular regulation of the B 2 R interactions with the G proteins, GRKs, or arrestins. Thus, it is not clear, whether the same or different domains of the B 2 R convey the active state of the receptor and are involved in coupling of the various signaling proteins.
As a typical GPCR of family A, the B 2 R contains the NPxxY sequence at the end of helix 7 and most likely the intracellular helix 8, linked at the N-terminus to the NPxxY sequence by a four amino acid spacer and anchored at its Cterminus through palmitoylated cysteines to the inner leaflet of the plasma membrane. Helix 8 was first identified in the crystal structure of bovine rhodopsin (6) and later with the exception of CXCR4 (7) also in the other resolved structures of GPCRs (8) . It is lying perpendicular to the seven transmembrane domain bundle of GPCRs and has been reported to move significantly upon receptor activation (9, 10) . Therefore, helix 8 is an excellent candidate for the agonist-induced recognition of and interaction with cytosolic binding partners and has been studied extensively in several GPCRs. Studies have not only shown the involvement of helix 8 in G protein activation (11) (12) (13) (14) (15) but also identified hydrophobic residues in helix 8 as being essential for the surface expression of the GPCRs investigated (11, 16, 17) . In addition, it has been published only recently that mutation of positively charged residues in helix 8 of the TRH receptor prevented GRK-mediated receptor phosphorylation (18) .
As demonstrated by our research group, mutation of Tyr7.53 (Ballesteros/Weinstein nomenclature (19) ) to an alanine in the NPxxY sequence resulted in constitutive receptor phosphorylation and internalization (20) . Homology modeling indicated that Tyr7.53 in the B 2 R exerts an aromatic stacking interaction with the highly conserved phenylalanine Phe7.60 in helix 8. Thus, we speculated that the properties of mutant Tyr7.53 are caused by a modified interaction with GRKs and arrestins involving helix 8. Further studies using chimera of the B 2 R with the non-sequestering bradykinin B 1 receptor also suggested that helix 8 might be involved directly or indirectly in the interaction of the B 2 R with GRKs and !-arrestins (21) .
Consequently, we investigated in the present study not only the function of helix 8 in the B 2 R with regard to surface expression and G protein activation, but also assessed its role in the desensitization process involving the interaction with GRKs and !-arrestins. Our results clearly demonstrate that helix 8 is involved in all of the before mentioned receptordependent processes, however to a different degree and with different requirements for the receptor microenvironment comprising helix 8.
EXPERIMENTAL PROCEDURES
Materials-Flp-In™ TREx-293 (HEK 293) cells, and Opti-MEM I serum free medium were obtained from Invitrogen (Karlsruhe, Germany). [2,3- (23) . Receptor constructs, GRK3, !-arrestin1 and !-arrestin2 genes were all cloned into the HindIII and the XhoI sites of the pcDNA5/FRT/TO vector (Invitrogen). The receptor sequences were preceded at the Nterminus by a single hemagglutinin-tag (MGYPYDVPDYAGS) with the last two amino acids (Gly-Ser) of the tag being generated by the insertion of a BamHI site. For the N-terminal eYFP (enhanced yellow fluorescent protein) fusion constructs the receptors were preceded by the signal sequence of the human frizzled receptor 4 followed by the coding sequence for the eYFP and the HA-tag. Cell culture and transfection-For stable expression of the constructs in HEK 293 cells we used the Flp-In system from Invitrogen as described previously (24) . For transient transfection cells were seeded into 24-wells (80% confluency) and transfected using 0.2 µg DNA and 0.4 µl EcoTransfect. Expression was induced with 0.5 µg/ml tetracycline 5-6 h after transfection and 16 h prior to the respective assay. For !-arrestin knockdown, monolayers (50% confluent) in 24-wells were treated with 125 ng siRNA/1. ]BK (>95% of totally bound radioactivity) was dissociated by a 10 min incubation with 0.2 ml of an ice-cold dissociation solution (0.5 M NaCl/0.2 M acetic acid, pH 2.7), transferred to a scintillation vial and counted in a !-counter after addition of scintillation fluid.
Determination of inositol phosphate (IP)
release-Phosphatidyl inositol hydrolysis was measured as previously described (24) . In brief, confluent cell monolayers (24-wells) were incubated overnight in 0.5 ml complete medium containing 1 "Ci [ 3 H]inositol/ml. The cells were pre-incubated for 90 min on ice in incubation buffer supplemented with 50 mM LiCl with or without addition of increasing concentrations of BK. Stimulation was started by placing the cells in a water bath at 37°C. After 30 min IP accumulation was stopped by exchanging the medium for 1.5 ml of ice-cold 20 mM formic acid solution. After 1 h on ice and application of the supernatant to AG 1-X8 columns total [ 3 H]inositol phosphates (IP) were determined as described before (24 (25) . In order to detect endogenous factors that might be limiting the process (e.g. !-arrestins) we used 5 nM or higher concentrations as indicated. Receptor downregulation-Monolayers (48-well) were incubated with or without 1 µM unlabeled BK in 0.5 ml Opti-MEM I for the indicated times at 37°C. Thereafter, plates were rinsed with ice-cold PBS and incubated on ice for 10 min with 0.2 ml dissociation solution to remove all unlabeled extracellular ligand. The cells were washed again with ice-cold PBS and specific binding was determined with 2 nM [ 3 H]BK at 4°C by subtracting nonspecific binding (determined in the presence of 5 "M unlabeled BK) from total surface binding. Co-immunoprecipitation-Confluent monolayers of cells stably expressing HA-tagged receptor constructs on 10 cm dishes were transfected with 5 "g plasmid harboring the respective constructs and 10 "l EcoTransfect 36 hours prior to coimmunoprecipitation. Cells were washed twice with PBS, warmed up to 37°C in a water bath and subsequently stimulated with 1 "M BK for the indicated times in 4.8 ml PBS. The stimulation was stopped by addition of 0.2 ml 25 mM cross-linking agent (DSP, dissolved in DMSO) to obtain 1 mM final concentration. After incubation for 20 min at room temperature, cells were rinsed three times with quenching solution (50 mM Tris-HCl, pH 7.4) and solubilised in 1 ml lysis buffer (10 mM TrisHCl, 25 mM KCl, 150 mM NaCl, 0.1% Triton X-100, pH 7.4) including protease inhibitors for 15 min at 4°C with gentle agitation. Following centrifugation at 6.240 x g for 15 min at 4°C, 20 "l of the supernatant was mixed with an equal amount of 2X LDS sample buffer containing 0.2 M DTT and incubated for 10 min at 95°C; the residual supernatant was added to 20 µl EZview red anti-HA affinity gel and incubated for 1 h under gentle agitation at 4°C. Thereafter, the anti-HA matrix was washed three times with icecold lysis buffer, then 30 "l of 1X LDS sample buffer containing 0.1 M DTT was added and the immunocomplexes were dissociated at 95°C for 10 min. Samples were separated on a 4-12% SDS-polyacrylamide gel and transferred to a 0.45 µm nitrocellulose membrane, which was blocked for 1 h at room temperature with milk powder dissolved in TBST (Tris-buffered saline, pH 7.5, 0.1% Tween 20) . Subsequently the membrane was incubated overnight at 4°C with anti-!-arrestin2 antibody (1:1000) or for 1 h at room temperature with anti-!-arrestin1-or anti-GRK3 antibody, each diluted 1:1000 in blocking buffer. Thereafter, the membrane was washed with TBST and incubated with HRP-linked goat anti-rabbit IgG diluted 1:2000 in blocking solution. For the recognition of the primary mouse anti-!-arrestin1 antibody the peroxidaselabeled anti-mouse true blot secondary antibody (1:2000) (eBioscience, San Diego, USA) was used. Antibody binding was detected using ECL solution according to the instructions of the manufacturer.
Immunoblotting-Confluent monolayers in 6-well trays were washed three times with ice-cold PBS and solubilized in 300 µl lysis buffer and cleared by centrifugation as described above. Aliquots of the supernatant were mixed with equal amounts of 2X LDS sample buffer (0.2 M DTT), incubated for 10 min at 95°C, and proteins were electrophoresed, electroblotted and detected as described above. For deglycosylation, 5 µl of 10X deglycosylation buffer (PBS, 20 mM EDTA, 1% SDS, 5% Triton-X100, 10% 2-mercaptoethanol) was added to 45 µl clear cell lysate and denatured at 80°C for 10 min. After addition of 1 U Nglycosidase F, the samples were incubated for 2 h at 37°C without agitation and mixed with 1X LDS sample buffer (0.1 M DTT). HA-tagged receptors were visualized after 1 h blocking in 5% milk powder at room temperature followed by 1 h incubation with a monoclonal HRPlinked anti-HA high affinity antibody (1:2000) diluted in fresh blocking buffer. Surface biotinylation-Cells stably expressing receptor constructs were plated on 6-wells and incubated for 3 h at 37°C in OPTI-MEM I containing ligand or vehicle. Subsequently, cells were washed with ice-cold PBS and incubated on ice for 30 min with a solution of 0.3 mg/ml of thiol-cleavable sulfo-NHS-SS-biotin (Pierce, Rockford, IL) dissolved in PBS. After cell-lysis, biotinylated receptors were precipitated and run on a SDS-PAGE as described above. Dissociation of precipitated receptors was performed in DTT-free Laemmli-buffer to avoid cleavage of the biotin-linker. After blotting, the receptors were detected with the Vectastain ABC Kit (Vector Laboratories, Burlingame, CA) according to the manufacturers instructions. ERK1/2 phosphorylationCells stably expressing GRKs 2-6 were plated on 24-wells and transfected with the B 2 Rwt H . After 12 hours the culture medium was changed for DMEM containing reduced FCS (0.5%) and 0.5 µg/ml tetracycline to induce gene expression. Another 36 hours later the cells were washed with icecold PBS and incubated on ice in 0.15 ml incubation buffer containing 1 µM BK. After 30 min the plates were put in a 37°C warm water bath for the indicated times. Subsequently the cells were solubilised in 0.2 ml lysis buffer and proteins were separated by SDS-PAGE as described above. Following electroblotting and blocking with 5% milk powder in TBST phospho-ERK1/2 and total-ERK1/2 were detected with phospho-p44/42 MAPK (E10) and a p44/42 MAP kinase (3A7) mouse monoclonal antibody (Cell Signaling, Frankfurt), respectively. Epifluorescence microscopy-Cells stably expressing eYFP-receptor fusion proteins were seeded on glass coverslips. The cell culture medium was changed to Opti-MEM I medium prior to incubation with 1 µM BK or 1 µM JSM10292. Images were taken with a Olympus IX70 fluorescence microscope. Data analysis-All experiments were performed at least three times in duplicates or triplicates, and results are given as mean ± SEM, unless otherwise indicated. Data analysis was carried out using GraphPad Prism for Macintosh, Version 4.0c (GraphPad Software, Inc.).
RESULTS

Helix 8 requirement for high B 2 R cell surface expression.
In order to investigate the importance of helix 8 for the function of the B 2 receptor (B 2 R), we generated several constructs with increased truncations of the C-terminus up to the center of helix 8 (Fig. 1A) . Moreover, to disturb the structure of helix 8 by a single point mutation leaving the B 2 R C-terminus otherwise unchanged, we mutated Lys315 -located in the center of helix 8 -to proline (construct K315P), a known helix breaker (Fig. 1A) . As a control that altered properties observed in K315P are not caused by Lys315 being an important residue per se, e.g. as a target for ubiquitination or for the overall receptor structure, mutant K315A was generated as well. Table 1 ). These results demonstrate that the distal C-terminus of the B 2 R is not required for high surface expression, but that an intact helix 8 contributes to it as being reported for other GPCRs (11, 16, 17, 26) . To be able to directly compare the properties of the different constructs without having to consider the potential influence of the highly different surface expression levels, we also generated cell lines, where the normally highly expressed constructs (B 2 Rwt, G327*, G322*, K315A) were expressed at distinctly lower levels under the control of the weaker P min promoter ( Fig. 1B ; Table 1 , constructs were denoted with inferior L or H for low and high expression, respectively). These distinctly lower surface expression levels were similar to those determined for mutants, which exhibit low levels, despite being under the control of the strong CMV promoter, i.e. constructs Y320*, V319*, K315P.
Immunoblot analysis of the expressed constructs using the N-terminal HA-tag revealed several bands between 45 and 75 kDa as well as prominent double-bands below 40 kDa (Fig. 1C , upper panel). All truncations made proximal to Cys324 (G322*, Y320*, Y319*) displayed a weaker pattern of bands between 40 and 75 kDa, but very strong double-bands. Pretreatment of protein lysates with N-glycosidase F resulted for all samples in the appearance of one additional major lower band and more intense double bands (Fig. 1C, lower panel) , demonstrating that the different bands reflect different glycosylation states, and that also the double-bands represent intact receptor protein and not degradation products. These results point to a role of helix 8 in the B 2 R in stabilizing a proper conformation that allows for full glycosylation and efficient trafficking to the plasma membrane.
Reduced G protein activation of helix 8 mutants. In order to determine the participation of helix 8 in G protein activation, we measured the accumulation of total inositol phosphates (IP) in the respective cell lines after stimulation with increasing concentrations of BK for 30 min at 37°C. Mutant G327*, lacking the whole Cterminus, exhibited an almost 30-fold lower EC 50 value than B 2 Rwt and also elevated levels (appr. 2-3 fold as compared to B 2 Rwt) of basal IP accumulation ( Fig. 2 These results show that lack of the receptor Cterminus with the phosphorylation sites only reduces rapid receptor sequestration, whereas a defective helix 8 prevents it almost completely as best demonstrated with K315P, a construct still comprising the complete C-terminus with all phosphorylation sites (Fig. 3A) .
Requirement of an intact helix 8 for sequestration upon long-term stimulation. We next investigated how the mutations affect the outcome of long-term stimulation by treating the cells with a saturating concentration of BK (1 µM) for up to 5 h at 37°C. Remaining surface binding was determined with 2 nM 3 [H]BK at 4°C after removal of all unlabeled BK with NaCl/acetic acid solution. As receptor sequestration is considerably slowed down per se by high expression levels of constructs (25), we used the stable cell lines expressing receptor genes under the control of the weaker P min promoter, when available. Cell surface binding was reduced by more than 80% after 30 min for the B 2 Rwt L and remained at that level for at least 5 hours (Fig. 3B) . Even though receptor numbers decreased strikingly slower for G327* L than for B 2 Rwt L , they reached a similarly low level after 5 h of BK treatment. The degree of receptor sequestration was progressively reduced with shortening the C-terminus and was completely prevented in mutation V319*, indicating that an intact helix 8 is crucial for the sequestration of the B 2 R. This notion was strengthened by the result that also mutant K315P showed no reduction of surface binding within the 5 h time frame of stimulation with BK, whereas K315A L behaved like B 2 Rwt L .
Epifluorescence microscopy with Nterminally eYFP-tagged constructs. In order to visualize the localization of selected receptor variants without affecting the function of the Cterminus, we generated fusion proteins with enhanced yellow fluorescent protein (eYFP) joined to their N-terminus. To allow for proper extracellular expression, the eYFP sequence was preceded by the signal sequence of the human frizzled 4 receptor as otherwise the fusion proteins were trapped inside the cell. The integrity of the fusion constructs was confirmed by Western blot analysis (not shown). Epifluorescence microscopy revealed a strongly dispersed intracellular localization of eYFP-V319* (not shown here) and of eYFP-K315P* (Fig. 4E) , whereas eYFP-B 2 Rwt (Fig. 4A ) and eYFP-G327* (Fig. 4C) were almost exclusively located at the plasma membrane. In these latter two cell lines, a strong redistribution of the receptors from the plasma membrane to intracellular vesicles after BK treatment became obvious, which proceeded more rapidly for B 2 Rwt (shown after 30 min, Fig. 4B ) than for G327* (shown after 120 min, Fig. 4D ), in accordance with the sequestration data given in Fig. 3B . The fusion constructs of V319* and K315P did not display any recognizable redistribution even upon prolonged stimulation (up to 5 h; not shown here). However, when these two constructs were treated for 3 h with the small molecule B 2 R antagonist JSM10292 ( (27) and manuscript submitted) they were found predominantly at the cell surface (shown here only for eYFP-K315P*, (Fig. 4F) .
These results were confirmed by cell surface biotinylation followed by immunoprecipitation. Whereas the number of biotinylated cell surface receptors was strongly reduced for B 2 Rwt and mutant G327* after a 3 h incubation with BK, no change was observed for mutant K315P (Fig. 4H) . However, for the latter mutant a significant increase was observed upon incubation with JSM10292 for 3 h (Fig. 4G and  4H) . A 16 h incubation of mutant K315P with this antagonist resulted even in a change to an immunoblot pattern that resembled that of the B 2 Rwt (Fig. 4I) . These results suggest that the said B 2 R antagonist can correct the trafficking to the plasma membrane, hampered by the disturbed helix 8. Together, these results confirm that rapid receptor internalization is dependent on the presence of the C-terminus. Yet, slower sequestration can occur in a C-terminusindependent way, too. For both processes, however, an intact helix 8 is crucial.
C-terminus-independent B 2 R internalization mediated by !-arrestin2. The ubiquitously expressed !-arrestins1 and 2 have been shown to target GPCRs to clathrin-coated pits through their interaction with clathrin and the adapter protein AP-2 thereby promoting receptor internalization (28, 29) . Furthermore, Simaan et al. have reported that in COS7 cells !-arrestin2 mediates B 2 R internalization (30) . To investigate whether C-terminal-dependent andindependent receptor endocytosis have different requirements for !-arrestins, we used siRNA technology to reduce the endogenous levels of !-arrestin1 and 2 in HEK 293 cells (Fig. 5B) .
Single knockdown of !-arrestin1 had no significant impact on B 2 Rwt internalization (Fig.  5A) . Knockdown of !-arrestin2 reduced receptor endocytosis by 40%, which could be further significantly decreased by an additional !-arrestin1 knockdown, indicating a partly compensatory effect of !-arrestin1 in the case of diminished !-arrestin2 levels (Fig. 5A) . The latter effect did not turn significant with a second set of !-arrestin siRNAs (Fig. S2A) . Comparing the two different sets of siRNAs for their ability to reduce overexpressed !-arrestin1 and 2 levels the first set proved to be much more efficient than the second (Fig. S2B) . This might explain why the additional effect of !-arrestin1 was not observed with the second siRNA set, as it can apparently be observed only with a highly efficient !-arrestin2 siRNA.
Receptor internalization of stably transfected G327* in HEK 293 cells was monitored using 1 nM [
3 H]BK for 15 min, since higher concentrations made receptor endocytosis hardly detectable for that mutant. Only knockdown of !-arrestin2, but not of !-arrestin1, significantly reduced internalization of G327* (Fig. 5A) . (Fig. 5D) . Only minor enhancing effects of !-arrestin2 but not of !-arrestin1 overexpression on [ 3 H]BK internalization of B 2 Rwt were observed (Fig.  5C ). However, under certain circumstances !-arrestin1 can also play a role in this process as !-arrestin1 overexpression was able to rescue internalization that had been reduced by siRNA knockdown of endogenous !-arrestin2 (Fig. 5C ). In contrast, overexpression of both !-arrestin subtypes strongly enhanced ligand-induced internalization of G327* with !-arrestin2 exhibiting a significantly larger impact (Fig.  5C) .
To directly assess the interaction of !-arrestins with receptor constructs, we performed co-immunoprecipitation with the chemical crosslinker DSP (dithiobis succinimidyl propionate) using cells stably overexpressing B 2 Rwt H or G327* H . Each cell line was transiently transfected with either !-arrestin1 or !-arrestin2. Both arrestins could be coimmunoprecipitated with the B 2 Rwt after 5 min stimulation (Fig. 5E ). Mutant G327* still bound !-arrestin2 -but not !-arrestin1 -upon BK treatment, albeit obviously to a lower extent than the B 2 Rwt. These results suggest that internalization of G327* and B 2 Rwt is largely mediated by the action of !-arrestin2, although !-arrestin1 is able to functionally compensate in part for !-arrestin2 under certain circumstances (e.g. such as overexpression of !-arrestin1 or after !-arrestin2 knockdown). Furthermore, the C-terminus of the B 2 R is less important for the interaction with !-arrestin2 than for coupling of !-arrestin1.
Regulation of B 2 R-induced ERK1/2 activation by GRK2 and GRK3.
GRKs phosphorylate almost exclusively agonistactivated receptors, and consequently there must be molecular determinants of the receptor that signal the agonist-bound status to the GRKs. We hypothesized that helix 8 might function as such a signaling determinant. Overexpression of the ubiquitously expressed GRKs 2-6 produced different phosphorylation pattern of the B 2 R after stimulation (31), however, so far it was not investigated whether this also results in different signaling outcomes. Therefore, we firstly determined in our study how overexpression of GRKs 2-6 in HEK293 cells (Fig. S1A ) affects ERK1/2 activation by the B 2 R. Of all here examined GRKs, only overexpression of GRK2 and 3 significantly reduced the ERK1/2 signal during the determination period of 30 min (Fig.  S1B and C) .
Promotion of phosphorylationindependent internalization by GRK3. As GRK3 displayed the strongest effect, we chose this kinase to investigate the importance of helix 8 for the interaction of the B 2 R with GRKs. Stimulation with BK resulted after 2 min in a stable interaction of GRK3 with the B 2 Rwt as well as with G327*, which lasted for at least 30 min (Fig. 6A) . Hence, GRK3 interaction can occur independently of the C-terminus, its substrate, raising the question whether there are other functions of GRKs besides the mere phosphorylation of the receptor C-terminus. Overexpression of GRK 2 or 3 resulted in minor, but significant increases in the internalization of the B 2 Rwt (not shown). However, also the internalization of G327* (lacking the C-terminus with all the phosphorylation sites) was significantly increased by overexpression of GRK3 (Fig. 6B) .
It has been shown that GRKs contain consensus clathrin-binding motifs through which they are able to promote receptor internalization (32, 33) . To discriminate whether clathrinbinding and/or kinase-activity promote internalization of G327*, we generated a GRK3 variant with a group-mutation of the clathrinbinding-motif to alanines ( 498 LLDCD 502 # 498 AAAAA 502 ; GRK3-5A) in addition to a kinase activity-deficient mutant GRK3-K220R (Fig.  6C) . Overexpression of GRK3-5A or GRK3-K220R did not increase significantly the internalization of G327* (Fig. 6B) . Thus, the capability of GRK3 to promote B 2 R endocytosis independently of the C-terminal phosphorylation sites requires still its kinase-activity and the simultaneous presence of the clathrin-binding motif.
Requirement of the receptor C-terminus for rescue of K315P internalization by GRK3
and !-arrestin2. Next, we investigated whether overexpression of GRK3 and !-arrestin1 or 2 would be able to rescue the internalization of mutant K315P, which had a disturbed helix 8 but otherwise an intact C-terminus. Overexpression of GRK3 resulted in a strong increase of ligandinduced internalization of K315P more than 2 fold, whereas that of the kinase-dead mutant GRK3-K220R did not, indicating the requirement of phosphorylation for the internalization process (Fig. 6D) . Internalization of K315P could also be rescued by !-arrestin overexpression independently of the subtype, albeit to a smaller extent as compared to GRK3 (Fig. 6D) . In contrast, in HEK 293 cells expressing the receptor mutant K315P-G327* (which combined the defective helix 8 with the lack of the distal C-terminus) neither overexpression of !-arrestins nor GRK3 could significantly re-induce internalization (Fig. 6E) , suggesting that the rescue by GRK3 or !-arrestins is strongly dependent on the presence of the intact C-terminus or an intact helix 8.
Requirement of a specific microenvironment for proper function of helix 8. Finally, to test whether C-terminal sequences and/or helices 8 of different GPCRs of family A are functionally transferable to the B 2 R, we generated various chimeras of the B 2 R with the C-termini/helices 8 of the protease-activated receptor-2 (PAR2), the ! 2 -adrenergic receptor (! 2 ADR), the angiotensin II type 1 receptor (AT1R) and the B 1 bradykinin receptor (B 1 R). Except B 1 R, all these receptors become phosphorylated and internalized after agonist stimulation (34) (35) (36) (37) .
All chimeric constructs (Fig. 7A) were robustly expressed on the cell surface (appr. 5-10 pmol!mg -1 protein -1 ) as determined by radioligand binding assays with [ 3 H]BK. The chimeras with transfer of the C-termini distal to helix 8 (B 2 CPAR2, B 2 CADR2, B 2 CB 1 ) showed strong PI hydrolysis (Fig. 7B) . For the other chimeras with transfer of helix 8 either with or without the distal C-terminus PI hydrolysis apparently depended on the source of helix 8. When helix 8 was derived from another G protein G q/11 -coupled GPCR (PAR2, AT1R), the chimeras displayed robust signaling, whereas there was no signaling when helix 8 was taken from the ! 2 ADR (constructs B 2 YADR2, B 2 YADR2CB 2 ) that couples to G protein G s .
Determination of receptor internalization showed a fast uptake of [ 3 H]BK in all chimeras with C-terminus exchanges distal of helix 8 (Fig.  7C) . Solely, when the C-terminus was derived from the non-internalizing B 1 R (construct B2CB1), a quite slow and low uptake was observed. When helix 8 was substituted in addition, only the AT1R chimera was able to function like the B 2 Rwt, whereas the other chimeras displayed hardly any [ 3 H]BK up-take at all. Taken together, these results indicate that G protein activation might require only a helix 8 of a "donor"-receptor that couples to the same G protein, whereas with regard to receptor internalization the structural requirements are much more specific for a helix 8 to function properly in a different receptor environment. In contrast, the C-terminus distal to helix 8 can apparently function to a great extent independently from the receptor core in the internalization process.
DISCUSSION
Helix 8 and surface expression.
The existence of an intracellularly located 8th helix has been predicted for some GPCRs (reviewed in (38) ) and than confirmed with the resolution of the first structure of a GPCR, the inactive rhodopsin (6) . All following structures also displayed this helix 8 (8) with the exception of CXCR4 (7). One reason for this high conservation seems to be an important role of helix 8 in stabilizing the receptor in a conformation that supports trafficking to the plasma membrane. In this respect, it has been reported for several GPCRs that truncation of the C-terminus up into the region of helix 8 results in a strong loss of receptor surface expression (11, 16, 17, 26) . Our results with the receptor chimeras and in particular with the helix 8 point mutant K315P of the B 2 R, suggest that for the presumably stabilizing effect of helix 8 its specific amino acid composition is less important than maintaining its overall helical structure: all our chimeric constructs with complete transfers of helix 8 from one receptor to another were robustly expressed, but disturbance of helix 8 in the B 2 R (point mutant K315P) resulted in much lower surface binding than observed for the B 2 Rwt H accompanied by strong intracellular localization (Fig. 4E) .
As published recently, for the leukotriene B4 type-2 (BLT2) receptor an intact helix 8 is required for the receptor to pass the quality control process in the endoplasmatic reticulum (17) . In line with this report, Western blot analysis of our constructs showed that most of the newly synthesized helix 8-defective receptor proteins are apparently insufficiently glycosylated and trapped inside the cell. The observation that the helix 8-truncated construct V319* as well as construct K315P reached the surface when a membrane-permeable antagonist was added (Fig. 4F) , suggests that the receptor molecule in the absence of a functional helix 8 can be stabilized by other means, e.g. an appropriate antagonist. A similar pharmacological chaperone effect was also reported for helix 8-defective mutants of the BLT2 receptor (17) and for the muscarinic M 1 receptor (14), implying a potential therapeutic approach to rescue respective defective receptors.
Helix 8 and G protein activation. Structural data and experimental approaches suggested that after binding an agonist on the extracellular site, helix 8 might be one of the key elements for transferring the information into the cell through becoming accessible for recruitment and activation of intracellular signaling proteins (9, 39, 40) . There is now substantial experimental evidence for the involvement of helix 8 (11) (12) (13) (41) (42) (43) (44) in the process of G protein activation, e.g. for several GPCRs it has been reported that truncation or deletion of helix 8 results in reduced activation (11) (12) (13) 44) . Moreover, earlier studies have demonstrated that peptides derived from the helix 8 of rhodopsin (41) or the angiotensin II receptor (42, 43) can directly interact with the respective G proteins. It has also recently been reported that the modified Cterminus of the G protein subunit G q can be crosslinked to several helix 8 residues of the muscarinic M3 receptor (45) . Pointing in the same direction of a direct involvement of helix 8 in the interaction with the G proteins, all our B 2 R mutants with a disturbed helix 8 displayed a distinct increase in the EC 50 values for PI hydrolysis as compared to the B 2 Rwt.
Helix 8 and B 2 R-GRK interaction.
Whereas the publications so far have focused almost exclusively on a role of helix 8 in receptor expression or in G protein activation, it was just recently reported that helix 8 might also play a role in receptor phosphorylation and therefore in the interaction with GRKs (18) . Mutation of basic residues in the helix 8 of the thyrotropin releasing hormone receptor (TRHR) resulted in reduced receptor internalization and phosphorylation that could be rescued partly by overexpression of GRK2 or 3 and fully by overexpression of GRK5 or 6. We have shown here that disturbance of helix 8 in the B 2 R by truncation or mutation of a central residue to a proline (construct K315P) strongly diminished ligand-induced receptor internalization. For K315P, this effect could in part be overcome through overexpression of GRK3 (or GRK2, data not shown here) but not of the kinaseinactive variant GRK3-K220R (or of GRK5 or GRK6, data not shown). Therefore, we suggest that helix 8 of the B 2 R participates directly or indirectly in specific high affinity binding of GRK3 (or GRK2). Accordingly, low affinity binding due to a defective helix 8 can be compensated for by GRK3 overexpression, which presumably results in normal phosphorylation of serine/threonine residues in the B 2 R C-terminus -if present -thus rescuing receptor internalization. In agreement with this proposal, rescue by GRK3 was not possible for construct K315P-G327*, having a defective helix 8 and lacking the C-terminus (Fig. 6E) . On the other hand, the reduced internalization observed for the B 2 R truncation G327*, caused by the absence of the receptor C-terminus with its phosphorylation sites, could also be partly rescued by overexpression of GRK3, but only when GRK3 kinase-activity was left functional and when the GRK3 clathrin-binding site was preserved. Together with the data that mutant G327* ligand-dependently binds GRK3 (Fig.  6A) , our results support the idea that receptorbound GRK3 may also phosphorylationindependently mediate directly internalization via clathrin-coated pits.
Helix 8 and arrestin interaction. Our results show that the presence of an intact helix 8 alone without the respective C-terminus is sufficient for the B 2 R to associate with !-arrestin2, but not with !-arrestin1, and to generate robust internalization, though to a distinctly lesser extent than observed for the B 2 Rwt. The combination of a disturbed helix 8 with C-terminal truncation (mutant K315P-G327*) completely abrogates receptor endocytosis and prevents even any rescue attempts by overexpression of !-arrestins. These data indicate that helix 8 is crucial to recruit preferably !-arrestin2 to the activated receptor and that preceding phosphorylation of the B 2 R C-terminus might ensure high affinity !-arrestin2 binding but is not absolutely required for a productive interaction. In contrast, !-arrestin1 is likewise strictly dependent on the B 2 R C-terminus, as it does not associate notably with construct G327*, at least not under the conditions applied (Fig. 5E ). However, it may substitute for !-arrestin2 in the sequestration of the B 2 R and even of G327* when !-arrestin2 levels are markedly reduced (siRNA knockdown) or with !-arrestin1 being strongly overexpressed (Fig. 5C ). Our observed subtype specific differences are in good agreement with a report by Zhang and co-workers who have previously shown that the phosphorylationindependent internalization of the $-opioid receptor is regulated via !-arrestin2, but not via !-arrestin 1, which promotes exclusively the phosphorylation-dependent internalization (46, 47) . Résumé. Our data support the following models for the activation of the B 2 R: subsequent to an agonist-induced change in the overall receptor conformation, helix 8 becomes accessible as an interaction site not only for G proteins but also for GRK2/3 and for !-arrestin2, yet less for !-arrestin1. With regard to receptor internalization of the B 2 R, helix 8 is apparently more important than the remaining C-terminus with its phosphorylation sites, as ligand-induced receptor internalization was still functional in the absence of the C-terminus, but completely abrogated when helix 8 was disturbed by a proline point mutation. Alternatively, helix 8 
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The expert technical assistance of Mrs. C. Seidl and Mrs. H. Grondinger is gratefully acknowledged. or G327* H were transiently transfected with !-arrestin1 (left) or !-arrestin2 (right) and stimulated (or not) with 1 µM BK for 5 min at 37°C. Following crosslinking with DSP and cell lysis, the protein complexes were precipitated with anti-HA-matrix. Precipitates were separated by reducing SDS-PAGE, transferred onto nitrocellulose membranes, and probed for !-arrestin1 (left) or !-arrestin2 (right) (top panels). Blots were stripped and re-probed to confirm receptor expression (middle panels) and lysates were tested for !-arrestin expression (bottom panels). IP, immunoprecipitation; IB, immunoblot. Fig. 6 . C-terminus-independent GRK interaction and rescue of K315P internalization. A, HEK 293 cells stably expressing HA-tagged B 2 Rwt or G327* were transiently transfected with GRK3 and stimulated (or not) with 1 µM BK for 2 or 30 min at 37°C. Following crosslinking with DSP and cell lysis, the protein complexes were precipitated with anti-HA-matrix. Precipitates were separated by reducing SDS-PAGE, transferred onto nitrocellulose membranes, and probed for GRK3 (top panel). Blots were stripped and re-probed to confirm receptor expression (middle panel), and lysates were probed for GRK expression (bottom panel). B, cells stably expressing GRK3wt, GRK3-5A or GRK3-K220R were transiently transfected with G327* and internalization was monitored with 1 nM [ 3 H]BK for 15 min at 37°C.. Significance was determined by one-way ANOVA using Bonferroni`s multiple comparison test. ***: p<0.001. C, representative immunoblot of cell lysates using ~2 µg protein of cells (over)expressing GRK3wt, GRK3-K220R and GRK3-5A. D and E, HEK 293 cells stably (over)expressing the indicated !-arrestin subtypes or GRK3 constructs were either transiently transfected with K315P or K315P-G327*. Internalization was monitored for 15 min at 37°C with 1 nM [ 3 H]. Significance was determined by one-way ANOVA using Bonferroni`s multiple comparison test. ***: p<0.001 Fig. 7 . Internalization and signaling of chimeric constructs. A, alignment of the C-terminal residues of the human B 2 Rwt swapped with sequences of various other GPCRs (marked in bold). Sequences were exchanged directly after the NPxxY motif of transmembrane helix 7 or after the proximal Cys324, respectively. The predicted helix 8 is framed. B, IP release of B 2 Rwt and chimeras, stably expressed in HEK 293 cells, was determined with 1 "M BK as described in Experimental Procedures. The results are presented as fold increase over the IP content of identically treated control cells that had remained on ice. C, internalization of B 2 Rwt and chimeras stably expressed in HEK 293 cells was determined as described in Experimental Procedures. 
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